Gyermekkori daganatok: vizsgálatok itt: Olaszország
205 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in OlaszországFight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
- Where
- Bologna, Genova, Milan, Padova, Pisa, Roma, Torino
- Életkor
- 4 év and over
- People
- 530 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07871864 - 1/2. fázisTaking peopleStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Bologna, Ravenna
- Életkor
- 16 év and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - No phaseNot yet taking people in OlaszországHealthcare Providers' Attitudes Toward Oncology Patients With Mental Disorders
- Where
- Aviano, Bari, Meldola, Padova, Rionero in Vulture
- People
- 1000
- Run by
- Istituto Oncologico Veneto IRCCS
See details and how to joinNCT07748221 - 3. fázisTaking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Alexandria, Bari, Bergamo, Bologna, Brescia, Candiolo, Florence, Genoa, Meldola, Milan, Modena, Monza, Naples, Palermo, Pavia, Perugia, Pesaro, Pisa, Reggio Calabria, Reggio Emilia, Rimini, Rome, Turin, Udine
- Életkor
- 12 év and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - 1. fázisTaking peopleAllogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL
- Where
- Rome
- Életkor
- 1 év to 35 év
- People
- 24
- Run by
- Bambino Gesù Hospital and Research Institute
See details and how to joinNCT06080191 - 2/3. fázisNot yet taking people in OlaszországFramework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
- Where
- Roma
- Életkor
- 3 hónap to 25 év
- People
- 1000 worldwide
- Run by
- Bambino Gesù Hospital and Research Institute
See details and how to joinNCT07297914 · EU 2025-522052-13-00 - 3. fázisBefejeződöttA Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- Where
- Milan, Pavia, Roma, Torino
- People
- 115 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT03394365 · EU 2024-516622-57-00 - 3. fázisTaking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Catania, Cosenza, Florence, Genoa, Monza, Naples, Padova, Palermo, Parma, Pavia, Rome, Trieste, Turin, Verona
- Életkor
- 1 nap to 1 év
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - No phaseTaking peopleProspective Multicenter Study of the Genomic, Transcriptomic, and Biological Profile of Patients With Neuroblastoma
- Where
- Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Catania, Catanzaro, Cosenza, Ferrara, Florence, Genova, Milan, Modena, Naples, Padova, Palermo, Parma, Pavia, Perugia, Pescara, Pisa, Reggio Calabria, Rimini, Roma, San Giovanni Rotondo, Sassari, Siena, Torino, Trieste, Verona
- Életkor
- 0 nap to 31 év
- People
- 200
- Run by
- Istituto Giannina Gaslini
See details and how to joinNCT07881172 - 1/2. fázisTaking peopleCARCIK CD123/33 for Refractory/Relapsed AML and BPDCN in Children and Adults
- Where
- Bergamo, Monza
- Életkor
- 6 hónap to 75 év
- People
- 18
- Run by
- Fondazione Matilde Tettamanti Menotti De Marchi Onlus
See details and how to joinNCT07877610 - 1/2. fázisTaking peopleAZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Where
- Bergamo, Bologna, Meldola, Monza, Naples, Rome
- Életkor
- 12 év and over
- People
- 255 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00 - 1/2. fázisTaking peopleAZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Where
- Alessandria, Bologna, Milan
- Életkor
- 12 év and over
- People
- 161 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00 - 1/2. fázisTaking peopleA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- Bologna, Meldola, Milan, Rome, Vicenza
- Életkor
- 30 nap and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00 - 1. fázisTaking peopleZiftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
- Where
- Monza, Rome
- Életkor
- 0 év to 21 év
- People
- 20 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT06376162 · EU 2023-505262-28-00 - No phaseTaking peopleMPNdpoint. Single-center, Retrospective, Prospective Study of the Outcome of Patients With Philadelphia-negative Chronic Myeloproliferative Neoplasms
- Where
- Milan
- Életkor
- 16 év and over
- People
- 1190
- Run by
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
See details and how to joinNCT07863466 - 1/2. fázisNot yet taking people in OlaszországStudy of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL
- Where
- Genoa, Monza, Rome
- Életkor
- Up to 64 év
- People
- 22 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-522019-40-00 - 2/3. fázisTaking peopleSafety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Where
- Alexandria, Ancona, Bari, Bergamo, Candiolo, Genoa, Messina, Milan, Modena, Padova, Rome, San Giovanni Rotondo, Siena, Trento
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00 - 1/2. fázisTaking peopleA Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Where
- Milan, Rome, Turin
- Életkor
- 1 hónap to 17 év
- People
- 50 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06941272 · EU 2024-518771-66-00 - 1. fázisTaking peopleA Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Where
- Rome
- Életkor
- 6 hónap to 17 év
- People
- 18 worldwide
- Run by
- AbbVie
See details and how to joinNCT07306832 - 1/2. fázisTaking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Candiolo, Milan, Naples, Rome, Rozzano
- Életkor
- 12 év and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - 1. fázisTaking peopleGD2-CAR T Cells for Pediatric Brain Tumours
- Where
- Roma
- Életkor
- 6 hónap to 30 év
- People
- 54
- Run by
- Bambino Gesù Hospital and Research Institute
See details and how to joinNCT05298995 - 1/2. fázisTaking peopleA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Milan
- Életkor
- Up to 25 év
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00 - 1/2. fázisTaking peopleA Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Where
- Ancona, Bari, Milan, Padova, Ravenna, Rome
- Életkor
- 12 év and over
- People
- 359 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05118789 · EU 2024-511793-71-00 - 2. fázisTaking peopleA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
- Where
- Bologna, Catania, Genova, Monza, Naples, Padova, Palermo, Pavia, Rome, Torino, Trieste
- Életkor
- 1 év to 17 év
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00 - 3. fázisTaking peopleRandomized study to protect from radiation iatrogenic hypothyroidism patients with medulloblastoma (any stage, any biological risk) and pediatric patients with Hodgkin lymphoma and non-Hodgkin lymphoma needing radiation therapy on thyroid site - WINHYPO 2021
- Where
- Milan
- People
- 65
- Run by
- Fondazione IRCCS Istituto Nazionale Dei Tumori
See details and how to join2024-512642-42-00